InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001601830-24-000047 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-03 2024-05-01+ RXRX Gibson Christopher CEO, Dir S - Sale $8.10 -100.0K 834.8K -11% -$810.0K
D 2024-05-03 2024-05-02 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +21.3K 856.1K +3% $0
D 2024-05-03 2024-05-01 RXRX Gibson Christopher CEO, Dir G - Gift $0.00 -25.0K 913.5K -3% $0
D 2024-05-03 2024-05-02 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -21.3K 6.43M -0.3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-05-01 S D 50,000 $7.73 863,524 D — —
2 Common Class A Common Stock 2024-05-02 C A 21,296 $0.00 856,116 D — —
3 Common Class A Common Stock 2024-05-02 S D 21,296 $8.47 834,820 D — —
4 Common Class A Common Stock 2024-05-01 G D 25,000 $0.00 913,524 D — —
5 Common Class A Common Stock 2024-05-02 S D 28,704 $8.47 834,820 D — —
6 Derivative Class B Common Stock 2024-05-02 C D 21,296 $0.00 6,426,700 D $0.00 · — to — 21,296 Class A Common Stock (F4) This number of shares represents the correct number of shares of Class B shares held by the Reporting person as of the date of this report, correcting an error in his running total from 2023. (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.